AR088984A1 - Aril y/o heteroaril carboxamidas utiles como endoparasiticidas en animales o seres humanos - Google Patents

Aril y/o heteroaril carboxamidas utiles como endoparasiticidas en animales o seres humanos

Info

Publication number
AR088984A1
AR088984A1 ARP120104427A ARP120104427A AR088984A1 AR 088984 A1 AR088984 A1 AR 088984A1 AR P120104427 A ARP120104427 A AR P120104427A AR P120104427 A ARP120104427 A AR P120104427A AR 088984 A1 AR088984 A1 AR 088984A1
Authority
AR
Argentina
Prior art keywords
alkyl
alkynyl
haloalkyl
alkenyl
haloalkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ARP120104427A
Other languages
English (en)
Inventor
Dr Harder Achim
Dr Welz Claudia
Dr Schwarz Hans
Georg-Dr Trautwein Axel
Dr Willms Lothar
Dr Forstner Maike
Dr Lmmen Peter
Grgens Ulrich
Coqueron Pierre-Yves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Publication of AR088984A1 publication Critical patent/AR088984A1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1: Compuestos según la fórmula (1) en la que X representa fenilo, tienilo o furanilo sustituidos una o varias veces con M¹; Q representa piridilo, tienilo, furanilo o isotiazolilo sustituidos una o varias veces con M¹; Y representa hidrógeno o alquilo C₁₋₁₀, alquenilo C₂₋₁₀, alquinilo C₂₋₁₀, haloalquilo C₁₋₁₀, haloalquenilo C₂₋₁₀, haloalquinilo C₂₋₁₀, alcoxi C₁₋₁₀, alquenil C₂₋₁₀-oxi, alquinil C₃₋₁₀-oxi, cicloalquil C₃₋₁₄-alquilo C₁₋₁₀ dado el caso sustituidos una o varias veces con M² o representa un grupo cíclico de 3 a 14 miembros dado el caso sustituido una o varias veces con M²; W representa oxígeno o azufre; L¹ representa -C(R¹¹,R¹²)-, oxígeno, azufre o -N(R¹)-; L² representa -C(R²¹,R²²)-; L³ representa -C(R³¹,R³²)- o un enlace directo; M¹ representa hidrógeno, halógeno, ciano, nitro, OH, alquilo C₁₋₁₀, haloalquilo C₁₋₁₀, alcoxi C₁₋₁₀, haloalcoxi C₁₋₁₀, alquil C₁₋₁₀-tio, haloalquil C₁₋₁₀-tio, alquil C₁₋₁₀-sulfonilo, haloalquil C₁₋₁₀-sulfonilo, alquil C₁₋₁₀-sulfanilo, haloalquil C₁₋₁₀-sulfanilo, (grupo cíclico de 3 a 14 miembros)-O-; R¹ representa hidrógeno o alquilo C₁₋₁₀, alquenilo C₂₋₁₀, alquinilo C₂₋₁₀, haloalquilo C₁₋₁₀, haloalquenilo C₂₋₁₀, haloalquinilo C₂₋₁₀, cicloalquil C₃₋₁₀-alquilo C₁₋₁₀ dado el caso sustituidos una o varias veces con M² o representa un grupo cíclico de 3 a 14 miembros dado el caso sustituido una o varias veces con M²; R¹¹, R¹² representan en cada caso independientemente uno de otro hidrógeno, halógeno o alquilo C₁₋₁₀, alquenilo C₂₋₁₀, alquinilo C₂₋₁₀, haloalquilo C₁₋₁₀, haloalquenilo C₂₋₁₀, haloalquinilo C₂₋₁₀, alcoxi C₁₋₁₀, alquenil C₂₋₁₀-oxi, alquinil C₃₋₁₀-oxi, cicloalquil C₃₋₁₄-alquilo C₁₋₁₀ dado el caso sustituidos una o varias veces con M² o representa un grupo cíclico de 3 a 14 miembros dado el caso sustituido una o varias veces con M²; R¹¹, R¹² conjuntamente representan un grupo carbocíclico de 3 a 14 miembros o heterocíclico de 3 a 10 miembros unido de forma espiro en cada caso y, dado el caso, sustituido una o varias veces con M²; R²¹, R²² representan en cada caso, independientemente uno de otro, hidrógeno, halógeno o alquilo C₁₋₁₀, alquenilo C₂₋₁₀, alquinilo C₂₋₁₀, haloalquilo C₁₋₁₀, haloalquenilo C₂₋₁₀, haloalquinilo C₂₋₁₀, alcoxi C₁₋₁₀, haloalcoxi C₁₋₁₀, alquenil C₂₋₁₀-oxi, alquinil C₃₋₁₀-oxi, cicloalquil C₃₋₁₄-alquilo C₁₋₁₀ dado el caso sustituidos una o varias veces con M² o representa un grupo cíclico de 3 a 14 miembros dado el caso sustituido una o varias veces con M²; R²¹, R²² conjuntamente representan un grupo carbocíclico de 3 a 14 miembros o heterocíclico de 3 a 10 miembros unido de forma espiro en cada caso y, dado el caso, sustituido una o varias veces con M²; R³¹, R³² representan en cada caso, independientemente uno de otro, hidrógeno o alquilo C₁₋₁₀, alquenilo C₂₋₁₀, alquinilo C₂₋₁₀, haloalquilo C₁₋₁₀, haloalquenilo C₂₋₁₀, haloalquinilo C₂₋₁₀, cicloalquil C₃₋₁₄-alquilo C₁₋₁₀ dado el caso sustituidos una o varias veces con M² o representa un grupo cíclico de 3 a 14 miembros dado el caso sustituido una o varias veces con M²; R³¹, R³² conjuntamente representan un grupo carbocíclico de 3 a 14 miembros o heterocíclico de 3 a 10 miembros unido de forma espiro en cada caso y, dado el caso, sustituido una o varias veces con M²; M² representa en cada caso, independientemente uno de otro, halógeno, formilo, ciano, nitro, alquilo C₁₋₁₀, haloalquilo C₁₋₁₀, alquenilo C₂₋₁₀, haloalquenilo C₂₋₁₀, alquinilo C₂₋₁₀, haloalquinilo C₂₋₁₀, alcoxi C₁₋₁₀, haloalcoxi C₁₋₁₀, alquenil C₂₋₁₀-oxi, haloalquenil C₂₋₁₀-oxi, alquinil C₃₋₁₀-oxi, haloalquinil C₃₋₁₀-oxi, alquil C₁₋₁₀-tio, haloalquil C₁₋₁₀-tio, alquenil C₂₋₁₀-tio, haloalquenil C₂₋₁₀-tio, alquinil C₃₋₁₀-tio, haloalquil C₃₋₁₀-tio, alquil C₁₋₁₀-sulfonilo, haloalquil C₁₋₁₀-sulfonilo, alquenil C₂₋₁₀-sulfonilo, haloalquenil C₂₋₁₀-sulfonilo, alquinil C₃₋₁₀-sulfonilo, haloalquinil C₃₋₁₀-sulfonilo, alquil C₁₋₁₀-sulfanilo, haloalquil C₁₋₁₀-sulfanilo, alquenil C₂₋₁₀-sulfanilo, haloalquenil C₂₋₁₀-sulfanilo, alquinil C₃₋₁₀-sulfanilo, haloalquinil C₃₋₁₀-sulfanilo, alquil C₁₋₁₀-carbonilo, haloalquil C₁₋₁₀-carbonilo, alquenil C₂₋₁₀-carbonilo, haloalquenil C₂₋₁₀-carbonilo, alquinil C₂₋₁₀-carbonilo, haloalquinil C₂₋₁₀-carbonilo, alcoxi C₁₋₁₀-carbonilo, haloalcoxi C₁₋₁₀-carbonilo, alquenoxi C₂₋₁₀-carbonilo, haloalquenoxi C₂₋₁₀-carbonilo, alquinoxi C₃₋₁₀-carbonilo, haloalquinoxi C₃₋₁₀-carbonilo, alquil C₁₋₁₀-carboniloxi, haloalquil C₁₋₁₀-carboniloxi, alquenil C₂₋₁₀-carboniloxi, haloalquenil C₂₋₁₀-carboniloxi, alquinil C₂₋₁₀-carboniloxi, haloalquinil C₂₋₁₀-carboniloxi, grupo cíclico de 3 a 14 miembros; así como sus sales, N-óxidos y formas tautómeras; para su uso como medicamentos para combatir endoparásitos en animales o en seres humanos.
ARP120104427A 2011-11-25 2012-11-23 Aril y/o heteroaril carboxamidas utiles como endoparasiticidas en animales o seres humanos Pending AR088984A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11190735 2011-11-25

Publications (1)

Publication Number Publication Date
AR088984A1 true AR088984A1 (es) 2014-07-23

Family

ID=47216313

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104427A Pending AR088984A1 (es) 2011-11-25 2012-11-23 Aril y/o heteroaril carboxamidas utiles como endoparasiticidas en animales o seres humanos

Country Status (18)

Country Link
US (1) US9422276B2 (es)
EP (1) EP2782565B1 (es)
JP (1) JP6126115B2 (es)
CN (1) CN104203223A (es)
AR (1) AR088984A1 (es)
AU (3) AU2012342433A1 (es)
BR (1) BR112014012589A2 (es)
DK (1) DK2782565T3 (es)
ES (1) ES2762249T3 (es)
HR (1) HRP20192191T1 (es)
HU (1) HUE047738T2 (es)
LT (1) LT2782565T (es)
MX (1) MX349802B (es)
PL (1) PL2782565T3 (es)
PT (1) PT2782565T (es)
RU (1) RU2638830C2 (es)
SI (1) SI2782565T1 (es)
WO (1) WO2013076230A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2891492T3 (da) * 2012-08-30 2022-11-21 Univ Tokyo Endoparasit kontrol middel
TWI598325B (zh) * 2012-10-12 2017-09-11 Ｈ 朗德貝克公司 苯甲醯胺類
TW201507722A (zh) * 2013-04-30 2015-03-01 Bayer Cropscience Ag 做為殺線蟲劑及殺體內寄生蟲劑的ｎ－（２－鹵素－２－苯乙基）－羧醯胺類
WO2015004091A1 (en) 2013-07-12 2015-01-15 Syngenta Participations Ag Nicotinamide derivatives and their use against nematodes
US10952435B2 (en) * 2013-07-18 2021-03-23 Syngenta Participations Ag Pyridine-2-carboxamides as nematocides
UY35772A (es) 2013-10-14 2015-05-29 Bayer Cropscience Ag Nuevos compuestos plaguicidas
WO2015133512A1 (ja) * 2014-03-05 2015-09-11 国立大学法人 東京大学 内部寄生虫防除剤
UY36196A (es) 2014-07-25 2016-02-29 Bayer Animal Health Gmbh Compuestos para usar en el tratamiento antihelmíntico
GB201415569D0 (en) 2014-09-03 2014-10-15 C4X Discovery Ltd Therapeutic Compounds
UY36373A (es) 2014-10-28 2016-04-29 Bayer Animal Health Gmbh Compuestos para usarse en el tratamiento antihelmíntico
AU2016317836B2 (en) * 2015-09-04 2018-09-13 Corteva Agriscience Llc Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
GB201601703D0 (en) 2016-01-29 2016-03-16 C4X Discovery Ltd Therapeutic compounds
JP7184383B2 (ja) * 2018-02-01 2022-12-06 ザ・ユニバーシティ・オブ・シドニー 抗癌性化合物

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504484A (en) 1982-11-04 1985-03-12 Chevron Research Company Certain N,N-di-substituted-pyridine carboxamides, fungicidal compositions and fungicidal method of use
GB8403726D0 (en) 1984-02-13 1984-03-14 Shell Int Research Carboxamide derivatives
JPS6150969A (ja) 1984-08-20 1986-03-13 Nippon Kayaku Co Ltd ピリジン誘導体及びそれを有効成分とする農園芸用細菌病防除剤
DD247598A5 (de) 1985-04-04 1987-07-15 F. Hoffmann-La Roche U. Co. Ag,Ch Fungizide mittel
DE4032147A1 (de) 1990-10-10 1992-04-16 Bayer Ag Verwendung von substituierten 2-mercaptonicotinsaeurederivaten zur bekaempfung von endoparasiten, neue substituierte 2-mercaptonicotinsaeurederivate und verfahren zu ihrer herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
JPH09249648A (ja) 1996-03-18 1997-09-22 Dainippon Ink & Chem Inc ２，６−ジクロロイソニコチン酸フェノキシアルキルアミド誘導体及び農薬
DE19750012A1 (de) 1997-11-12 1999-05-20 Bayer Ag Isothiazolcarbonsäureamide
WO2001040223A2 (en) 1999-12-02 2001-06-07 Novartis Ag Aminoheterocyclylamides as pesticides and antiparasitic agents
ES2347521T3 (es) * 2000-02-16 2010-11-02 Ishihara Sangyo Kaisha, Ltd. Derivados de fenacilamina, produccion de los mismos y controladores de plagas que contienen los derivados.
JP2001316366A (ja) 2000-03-01 2001-11-13 Nippon Bayer Agrochem Co Ltd チオカルボキシアミド類及びその農業用殺菌剤として利用
DK1392281T3 (da) * 2000-12-20 2007-06-11 Novartis Ag Anti-endoparasitiske amidoacetonitriler
AU2002310099A1 (en) * 2001-05-22 2002-12-03 President And Fellows Of Harvard College Identification of anti-protozoal agents
AR039020A1 (es) * 2002-03-21 2005-02-02 Novartis Ag Compuestos de aminoacetonitrilo
RU2316548C2 (ru) 2002-08-12 2008-02-10 Байер Кропсайенс С.А. Новое производное 2-пиридилэтилбензамида, способ его получения, фунгицидная композиция, способ профилактического или лечебного подавления фитопатогенных грибков
EP1449841A1 (en) 2003-02-19 2004-08-25 Bayer CropScience SA New fungicidal compounds
DE10307845A1 (de) 2003-02-25 2004-09-02 Bayer Cropscience Gmbh Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
EP1500651A1 (en) 2003-07-25 2005-01-26 Bayer CropScience S.A. N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides
AR046757A1 (es) * 2003-12-10 2005-12-21 Novartis Ag Amidoacetonitrilos utiles como pesticidas
TWI368482B (en) 2003-12-19 2012-07-21 Bayer Sas New 2-pyridinylethylbenzamide derivatives
EP1548007A1 (en) 2003-12-19 2005-06-29 Bayer CropScience S.A. 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
EP1574511A1 (en) 2004-03-03 2005-09-14 Bayer CropScience S.A. 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
EP1710237A1 (en) 2005-04-08 2006-10-11 Bayer CropScience S.A. New heterocyclylethylbenzamide derivatives
US7825068B2 (en) 2005-04-08 2010-11-02 Bayer Cropscience Ag Heterocyclylethylcarboxamide derivatives
CA2608248A1 (en) 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Soluble epoxide hydrolase inhibitors and methods of using same
EP1787981A1 (en) 2005-11-22 2007-05-23 Bayer CropScience S.A. New N-phenethylcarboxamide derivatives
ES2549409T3 (es) 2005-11-22 2015-10-27 Bayer Intellectual Property Gmbh Nuevos derivados de N-(1-metil-2-feniletil)benzamida
EP1792901A1 (en) 2005-11-22 2007-06-06 Bayer CropScience S.A. N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
US7790770B2 (en) 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TWI435863B (zh) * 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd Ｎ-２-（雜）芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
CL2008000512A1 (es) * 2007-02-22 2008-08-29 Bayer Cropscience Sa Compuestos derivados de n-(3-fenilpropil)carboxamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos.
PT2132987E (pt) 2007-04-12 2016-06-07 Nihon Nohyaku Co Ltd Composição de agente nematicida e método de utilização do mesma
CL2008001647A1 (es) 2007-06-08 2008-10-10 Syngenta Participations Ag Compuestos derivados de feniletil-amida de acido-1h-pirazol-4-carboxilico; compuestos derivados de (feniletil)amina; metodo para controlar o prevenir la infestacion de plantas por parte de microorganismos fitopatogenos; y composicion para el control
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
BRPI0911814A2 (pt) 2008-08-01 2018-05-29 Bayer Cropscience Ag "composto, composição fungicida e método para o controle do fungo fitopatogênico de culturas"
CA2744509C (en) 2008-12-05 2013-10-22 Syngenta Participations Ag Novel pyrazole-4-n-alkoxycarboxamides as microbiocides
AU2010264703A1 (en) 2009-06-24 2012-02-02 Shire Llc Mexiletine amino acid and peptide prodrugs and uses thereof
UY33282A (es) * 2010-03-25 2011-09-30 Novartis Ag Composiciones endoparasiticidas
WO2011128989A1 (ja) 2010-04-14 2011-10-20 アグロカネショウ株式会社 ピラジン-2-カルボキサミド誘導体及びこれを有効成分とする殺菌剤
CN103415288B (zh) * 2011-03-02 2018-04-03 国立大学法人东京大学 体内寄生虫防除剂
AU2012331256A1 (en) * 2011-11-04 2014-05-22 Syngenta Participations Ag Pesticidal compounds

Also Published As

Publication number Publication date
PT2782565T (pt) 2020-01-07
HRP20192191T1 (hr) 2020-02-21
LT2782565T (lt) 2019-12-27
AU2019203000A1 (en) 2019-05-23
PL2782565T3 (pl) 2020-08-24
RU2014125466A (ru) 2015-12-27
RU2638830C2 (ru) 2017-12-18
MX2014006136A (es) 2014-07-28
AU2017239594A1 (en) 2017-10-26
NZ624536A (en) 2016-09-30
WO2013076230A1 (de) 2013-05-30
DK2782565T3 (da) 2020-01-02
JP6126115B2 (ja) 2017-05-10
JP2015504437A (ja) 2015-02-12
SI2782565T1 (sl) 2019-12-31
ES2762249T3 (es) 2020-05-22
MX349802B (es) 2017-08-14
US20140323736A1 (en) 2014-10-30
CN104203223A (zh) 2014-12-10
US9422276B2 (en) 2016-08-23
BR112014012589A2 (pt) 2017-06-20
EP2782565A1 (de) 2014-10-01
AU2012342433A1 (en) 2014-06-12
EP2782565B1 (de) 2019-11-06
HUE047738T2 (hu) 2020-05-28

Similar Documents

Publication Publication Date Title
AR088984A1 (es) Aril y/o heteroaril carboxamidas utiles como endoparasiticidas en animales o seres humanos
CL2019002796A1 (es) Compuestos de pirimidinio y sus mezclas para combatir plagas de animales.
SV2019005823A (es) Inhibidores de diacilglicerol aciltransferasa 2
CO6852096A2 (es) Métodos plaguicidasque utilizan compuestos de 3-piridil tiazol sustituidos y derivados para combatir las plagas de animales i
UY35810A (es) Compuestos de isoxazolina antiparasitarios y pesticidas
CR20120361A (es) Compuestos divalentes y heterocíclicos unidos por puente oxa relacionados con nicotina y métodos de preparación de los mismos
UY36609A (es) Derivados heterocíclicos bicíclicos condensados como pesticidas
AR106299A1 (es) Compuestos de piridona y fungicidas agrícolas y hortícolas que contienen dichos compuestos como ingrediente activo
UY32832A (es) Carboxamidas pesticidas
AR085410A1 (es) Derivados de pirazol heteroaril-sustituidos, composiciones pesticidas que los comprenden y su uso en el control de plagas
PE20151025A1 (es) Nuevos derivados de piridina
BR112014005683A2 (pt) derivados isotiazolina como compostos inseticidas
EA201501142A1 (ru) Гетероциклические соединения в качестве средств для борьбы с вредителями
CR20140195A (es) Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas
AR085153A1 (es) Composiciones pesticidas y procesos relacionados
BR112015014909A2 (pt) derivados de sulfureto de arilo e de sulfóxido de arilo como acaricidas e inseticidas
CR10356A (es) Derivados de 4-benzilphthalazinona 2-sustituidos como antagonistas de histamina h1 y h3
UY31933A (es) Compuestos de sulfoximinamida para combatir plagas animales
PE20151429A1 (es) Dihidropirimidinonas biciclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrofilica
CO6620004A2 (es) Piridinas sustituidas que tienen acción herbicida
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3
ECSP11010800A (es) Nuevos derivados de acilaminobenzamida
BRPI0916385A2 (pt) derivados de carbamatos de alquiltiazóis, sua respectiva preparação e sua respectiva aplicação em terapêutica
DOP2014000285A (es) Composicion herbicida que tiene actividad herbicida mejorada
AR090112A1 (es) Sulfinilaminobenzamidas efectivas como herbicidas

Legal Events

Date Code Title Description
FB Suspension of granting procedure